About
Oral chemotherapies
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (10)
Anton Berns
Anton Berns, PhD
Modra Pharmaceuticals
team_member
Chris Huiskamp
Chris Huiskamp
Modra Pharmaceuticals
team_member
Colin Freund
Colin Freund
Modra Pharmaceuticals
team_member
Eric van der Putten
Eric van der Putten
Modra Pharmaceuticals
team_member
Hemanshu Shah
Hemanshu Shah, PhD
Modra Pharmaceuticals
team_member
Jan Schellens
Jan Schellens, MD, PhD
Modra Pharmaceuticals
team_member
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
205
By Phase
PHASE2: 2PHASE1: 5
By Status
COMPLETED: 5WITHDRAWN: 2
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
Today
Hover over trial bars to see details
Recent Trials
NCT04028388Lead Sponsor
ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer
PHASE2Completed
135 participants
Started: Jul 17, 2019 · Completed: Nov 29, 2021
NCT03890744Lead Sponsor
ModraDoc006/r in Patients With Breast Cancer
PHASE2Completed
12 participants
Started: Jan 30, 2019 · Completed: Nov 9, 2020
NCT05242926Lead Sponsor
Absorption and Excretion of Oral Docetaxel
PHASE1Withdrawn
Started: Oct 31, 2017 · Completed: Jun 30, 2018
NCT05084456Lead Sponsor
Oral Docetaxel in Patients With Normal or Impaired Liver Function
PHASE1Withdrawn
Started: Jul 31, 2017 · Completed: Apr 30, 2020
NCT03147378Lead Sponsor
Food Effect Study of ModraDoc006 in Combination With Ritonavir
PHASE1Completed
18 participants
Started: May 10, 2017 · Completed: Apr 4, 2018
Locations (1)
Headquarters
Amsterdam, Netherlands
Map
Loading map...